Intrapartum Rotation from Methadone to Buprenorphine/Naloxone and Postpartum Macroinduction of Depot Buprenorphine ("Sublocade"): A Case Report

被引:0
|
作者
Hacker Teper, Matthew [1 ]
Chan, Kathryn [2 ]
Miller, Meredith [2 ]
Fairgrieve, Christopher [2 ,3 ]
Lurie, Erin [2 ,3 ]
机构
[1] Univ Toronto, Dept Med, Div Emergency Med, C David Naylor Bldg 6 Queens Pk Crescent West,3rd, Toronto, ON M5S 3H2, Canada
[2] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada
[3] Unity Hlth Network, Dept Addict Med, Toronto, ON, Canada
关键词
pregnancy; opioid use disorder; opioid agonist therapy; Sublocade; buprenorphine; fentanyl; Grossesse; Trouble de l'utilisation des opio & iuml; des; Traitement par agoniste opio & iuml; de; Bupr & eacute; norphine; Fentanyl; OPIOID USE DISORDER;
D O I
10.1097/CXA.0000000000000214
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction:Medications to treat opioid use disorder (MOUD) has been associated with improved maternal-fetal outcomes when compared with illicit opioid use during pregnancy. However, there remains ambiguity surrounding optimal strategies for initiating and rotating MOUD for pregnant patients. This manuscript aims to introduce a novel approach to rotating a patient from methadone to sublingual buprenorphine/naloxone during pregnancy, followed by a rapid macrodosing titration to depot buprenorphine in the immediate postpartum period.Methods:This is a case report. It follows one patient's experience with illicit opioid use and MOUD in the peripartum period.Results:While the patient completed an uncomplicated intrapartum in-hospital rotation from methadone to sublingual buprenorphine/naloxone at 26 weeks gestation, she discontinued MOUD and resumed illicit opioid use 1 week later. The patient successfully completed a macroinduction of depot buprenorphine immediately postpartum and has since remained adherent to monthly depot injections and abstinent from illicit opioids for 5 months and counting.Conclusions:This manuscript details a unique and effective approach to a rotation of a pregnant patient from methadone to sublingual buprenorphine/naloxone via low-dose initiation, plus rapidly initiating depot buprenorphine immediately postpartum via macrodosing. Details of these protocols may aid future obstetrical addiction providers in optimizing opioid management for their patients. Introduction:M & eacute;dicaments pour traiter les troubles li & eacute;s & agrave; la consummation d'opiac & eacute;s a & eacute;t & eacute; associ & eacute; & agrave; une am & eacute;lioration des r & eacute;sultats maternels-f oe taux par rapport & agrave; la consommation d'opio & iuml;des illicites pendant la grossesse. Cependant, l'ambigu & iuml;t & eacute; demeure quant aux strat & eacute;gies optimales d'instauration et de rotation du m & eacute;dicaments pour traiter les troubles li & eacute;s & agrave; la consummation d'opiac & eacute;s chez les patientes enceintes. Ce manuscrit vise & agrave; pr & eacute;senter une nouvelle approche pour faire passer une patiente de la m & eacute;thadone & agrave; la bupr & eacute;norphine/naloxone sublinguale pendant la grossesse, suivie d'une titration rapide par macrodosage & agrave; la bupr & eacute;norphine par d & eacute;p & ocirc;t dans la p & eacute;riode post-partum imm & eacute;diate.M & eacute;thodes:Il s'agit d'un rapport de cas. Il retrace l'exp & eacute;rience d'une patiente qui a fait usage d'opio & iuml;des illicites et de son m & eacute;dicaments pour traiter les troubles li & eacute;s & agrave; la consummation d'opiac & eacute;s pendant la p & eacute;riode p & eacute;ri-partum.R & eacute;sultats:Bien que la patiente ait effectu & eacute; une rotation intra-partum sans complication de la m & eacute;thadone & agrave; la bupr & eacute;norphine sublinguale/naloxone & agrave; la 26e semaine de gestation, elle a interrompu le m & eacute;dicaments pour traiter les troubles li & eacute;s & agrave; la consummation d'opiac & eacute;s et repris l'usage d'opio & iuml;des illicites une semaine plus tard. La patiente a r & eacute;ussi une macro-induction de bupr & eacute;norphine par d & eacute;p & ocirc;t imm & eacute;diatement apr & egrave;s l'accouchement et est rest & eacute;e depuis lors fid & egrave;le aux injections mensuelles par d & eacute;p & ocirc;t en s'abstenant de consommer des opio & iuml;des illicites depuis maintenant cinq mois.Conclusions:Ce manuscrit d & eacute;crit une approche unique et efficace pour faire passer une patiente enceinte de la m & eacute;thadone & agrave; la bupr & eacute;norphine/naloxone sublinguale par initiation & agrave; faible dose, en plus de l'initier rapidement & agrave; la bupr & eacute;norphine par d & eacute;p & ocirc;t imm & eacute;diatement apr & egrave;s l'accouchement par macrodosage. Les d & eacute;tails de ces protocoles peuvent aider les futurs prestataires de soins obst & eacute;triques aux toxicomanes & agrave; optimiser la gestion des opio & iuml;des pour leurs patientes.
引用
收藏
页码:40 / 45
页数:6
相关论文
共 50 条
  • [1] eComparison of oral buprenorphine/naloxone, depot buprenorphine and methadone for patients released from custodial settings with opioid use disorder
    Shi, Avelyn
    Naz, Rokshar
    Hanby, Matthew F.
    McKenzie, Cameron R. L.
    Moe, Syed
    Dunlop, Adrian J.
    DRUG AND ALCOHOL REVIEW, 2023, 42 : S164 - S164
  • [2] TRANSFERRING FROM METHADONE TO DEPOT BUPRENORPHINE FORMULATIONS
    Lintzeris, Nicholas
    Dunlop, Adrian J.
    Hayes, Victoria
    Gottleib, Peter
    Demirkol, Apo
    DRUG AND ALCOHOL REVIEW, 2021, 40 : S99 - S99
  • [3] Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder - a case report
    Delic, M.
    EUROPEAN PSYCHIATRY, 2024, 67 : S415 - S415
  • [6] Reversal of central sleep apnoea with change from methadone to buprenorphine-naloxone: a case report
    Wang, David
    Lintzeris, Nicholas
    Leung, Stefanie
    Haber, Paul S.
    Yee, Brendon J.
    Grunstein, Ronald R.
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46 (04) : 1202 - 1205
  • [9] Buprenorphine/Naloxone and Dental Caries: A Case Report
    Suzuki, Joji
    Park, Eliza M.
    AMERICAN JOURNAL ON ADDICTIONS, 2012, 21 (05): : 494 - 495